新闻
2024-05-14
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracellular Protein Degraders to the Clinic
高管变更蛋白降解靶向嵌合体
2024-05-14
Merus:EGFR/LGR5双抗获FDA突破疗法认证,治疗头颈癌
突破性疗法AACR会议快速通道
2024-05-14
艾滋病感染风险降低91%!长效HIV疗法又一适应症在华获批
临床结果上市批准申请上市
2024-05-14
潜在首款!重磅抗炎药获FDA优先审评资格
优先审批申请上市临床研究
2024-05-13
MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy
引进/卖出
2024-05-13
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
上市批准优先审批临床结果
2024-05-13
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
快速通道蛋白降解靶向嵌合体
2024-05-13
再鼎医药1类创新药「瑞普替尼」国内获批上市!
上市批准并购优先审批
2024-05-13
全球首个!勃林格殷格翰公布创新抗体疗法早期积极临床结果
临床结果临床2期
2024-05-13
DCR为80%,迈威生物ADC疗法治疗乳腺癌临床结果公布
孤儿药快速通道抗体药物偶联物临床结果